Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.15 trillion and total revenue of $110.26 billion.
Market Cap
1.15T
Revenue
110.26B
Profits
-41.26B
PE Ratio
n/a
Profit Margin
-37.42%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.21B | 3.48% | 1,782,399 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.21B | 1.41% | 726,224 | 14.34B |
| 3 | ARGX | argenx SE | 47.54B | -0.60% | 464,356 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.15B | 0.51% | 1,605,949 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.17B | -1.67% | 364,133 | 5.34B |
| 6 | INSM | Insmed Incorporated | 32.19B | -0.45% | 2,716,323 | 606.42M |
| 7 | BNTX | BioNTech SE | 27.66B | 1.31% | 420,385 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 26.66B | 1.87% | 4,176,770 | 2.38B |
| 9 | MRNA | Moderna, Inc. | 21.16B | 3.60% | 9,052,883 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.71B | 1.58% | 4,313,386 | 13.31M |
| 11 | INCY | Incyte Corporation | 20.15B | 1.18% | 2,314,791 | 5.14B |
| 12 | RVMD | Revolution Medicines, Inc. | 20.10B | -0.13% | 10,308,314 | - |
| 13 | GMAB | Genmab A/S | 18.00B | 0.68% | 1,479,797 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.33B | 1.97% | 772,861 | 845.52M |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 13.14B | 0.68% | 2,781,245 | 944.00M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.89B | -1.67% | 2,261,430 | 502.08M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.86B | 5.00% | 2,401,010 | - |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.87B | 1.01% | 2,177,948 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.70B | 0.56% | 757,742 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.44B | -0.50% | 4,839,772 | 2.32B |
| 21 | RNAM | Avidity Biosciences, Inc. | 11.30B | 0.05% | 1 | 18.76M |
| 22 | IBRX | ImmunityBio, Inc. | 10.05B | 2.41% | 30,439,545 | 113.29M |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.91B | -3.11% | 407,432 | 958.40M |
| 24 | ABVX | ABIVAX Société Anonyme | 9.44B | 1.52% | 553,998 | 6.23M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.38B | -1.09% | 363,081 | 7.46M |
| 26 | TECH | Bio-Techne Corporation | 9.23B | 1.86% | 1,899,446 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.89B | 2.90% | 1,428,803 | - |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.86B | -0.19% | 1,866,075 | 1.09B |
| 29 | AXSM | Axsome Therapeutics, Inc. | 8.39B | 0.43% | 610,944 | 638.50M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.21B | 0.45% | 1,283,390 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 8.06B | -0.26% | 207,385 | 389.13M |
| 32 | NUVL | Nuvalent, Inc. | 7.92B | -1.91% | 667,546 | - |
| 33 | CYTK | Cytokinetics, Incorporated | 7.61B | -0.65% | 1,432,026 | 88.04M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 7.43B | -3.87% | 1,239,868 | 39.21M |
| 35 | BLTE | Belite Bio, Inc | 7.14B | 0.93% | 344,782 | - |
| 36 | ACLX | Arcellx, Inc. | 6.65B | -0.08% | 2,858,677 | 22.29M |
| 37 | COGT | Cogent Biosciences, Inc. | 6.26B | -1.55% | 1,744,964 | - |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.23B | -5.45% | 1,322,301 | 189.76M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.88B | 4.17% | 936,837 | 46.02M |
| 40 | CRSP | CRISPR Therapeutics AG | 5.77B | -2.59% | 1,690,516 | 3.51M |
| 41 | CAI | Caris Life Sciences, Inc. | 5.69B | 4.68% | 4,832,290 | 812.03M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.64B | 0.13% | 852,141 | 1.73B |
| 43 | IMVT | Immunovant, Inc. | 5.64B | 1.17% | 988,149 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | 0.11% | 1,018,659 | 521.31M |
| 45 | CELC | Celcuity Inc. | 5.17B | 0.53% | 643,780 | - |
| 46 | CGON | CG Oncology, Inc. | 4.74B | 4.79% | 1,062,866 | 4.04M |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.73B | 1.32% | 955,418 | - |
| 48 | TERN | Terns Pharmaceuticals, Inc. | 4.58B | 2.93% | 3,853,492 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.52B | -1.27% | 1,311,938 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.28% | 3,036,017 | 634.21M |
| 51 | TGTX | TG Therapeutics, Inc. | 4.40B | -2.62% | 1,961,105 | 616.29M |
| 52 | GPCR | Structure Therapeutics Inc. | 4.35B | -2.73% | 714,670 | - |
| 53 | ERAS | Erasca, Inc. | 4.23B | 0.66% | 5,971,685 | - |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.21B | -6.04% | 1,571,455 | 7.70M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 4.19B | -0.32% | 1,793,601 | 1.07B |
| 56 | NAMS | NewAmsterdam Pharma Company N.V. | 4.08B | 3.44% | 696,169 | 22.50M |
| 57 | CNTA | Centessa Pharmaceuticals plc | 3.92B | 0.34% | 462,868 | 15.00M |
| 58 | VKTX | Viking Therapeutics, Inc. | 3.91B | 2.64% | 2,039,947 | - |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 3.90B | 1.09% | 208,665 | 268.09M |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.80B | -0.22% | 1,408,931 | 761.41M |
| 61 | ADMA | ADMA Biologics, Inc. | 3.71B | 2.57% | 4,465,066 | 510.17M |
| 62 | ALMS | Alumis Inc. | 3.70B | -0.97% | 2,048,598 | 22.12M |
| 63 | LEGN | Legend Biotech Corporation | 3.51B | -1.45% | 1,654,217 | 909.05M |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.46B | -3.76% | 1,686,182 | 7.50M |
| 65 | SYRE | Spyre Therapeutics, Inc. | 3.38B | -0.32% | 695,080 | - |
| 66 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | -5.60% | 2,129,472 | 376.07M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.31B | -1.12% | 1,411,582 | - |
| 68 | EWTX | Edgewise Therapeutics, Inc. | 3.22B | 2.63% | 1,132,347 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.21B | -0.46% | 445,976 | 451.36M |
| 70 | VERA | Vera Therapeutics, Inc. | 2.90B | -3.68% | 1,312,038 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.83B | 0.94% | 753,270 | 218.71M |
| 72 | BEAM | Beam Therapeutics Inc. | 2.83B | -1.59% | 1,672,607 | 139.74M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.82B | -7.23% | 1,723,340 | 588.99M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.80B | -0.37% | 1,820,308 | 70.85M |
| 75 | TVTX | Travere Therapeutics, Inc. | 2.75B | 0.24% | 1,702,126 | 490.73M |
| 76 | LQDA | Liquidia Corporation | 2.70B | 0.75% | 1,307,973 | 69.22M |
| 77 | APLS | Apellis Pharmaceuticals, Inc. | 2.68B | -3.14% | 1,872,336 | 1.00B |
| 78 | WVE | Wave Life Sciences Ltd. | 2.62B | -9.31% | 3,738,448 | 42.73M |
| 79 | DYN | Dyne Therapeutics, Inc. | 2.57B | -3.52% | 1,930,060 | - |
| 80 | RCUS | Arcus Biosciences, Inc. | 2.55B | 4.25% | 1,912,457 | 247.00M |
| 81 | IRON | Disc Medicine, Inc. | 2.51B | -1.90% | 345,057 | - |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.46B | -2.67% | 2,049,500 | 276.98M |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.41B | -3.59% | 435,488 | 803.79M |
| 84 | IMNM | Immunome, Inc. | 2.41B | -0.14% | 1,053,184 | 9.68M |
| 85 | DNTH | Dianthus Therapeutics, Inc. | 2.39B | 3.92% | 835,081 | 3.08M |
| 86 | MLYS | Mineralys Therapeutics, Inc. | 2.32B | 0.79% | 708,763 | - |
| 87 | RARE | Ultragenyx Pharmaceutical Inc. | 2.26B | 1.52% | 1,404,794 | 673.00M |
| 88 | GLPG | Galapagos NV | 2.21B | 0.51% | 65,941 | 1.31B |
| 89 | AAPG | Ascentage Pharma Group International | 2.21B | 2.70% | 157 | 54.52M |
| 90 | MAZE | Maze Therapeutics, Inc. | 2.19B | -0.55% | 379,480 | 2.50M |
| 91 | ZLAB | Zai Lab Limited | 2.13B | -2.39% | 408,676 | 460.16M |
| 92 | STOK | Stoke Therapeutics, Inc. | 2.08B | 2.42% | 653,547 | 205.63M |
| 93 | MESO | Mesoblast Limited | 2.06B | -6.32% | 366,593 | 65.38M |
| 94 | NUVB | Nuvation Bio Inc. | 2.03B | 1.90% | 5,996,091 | 26.75M |
| 95 | SLNO | Soleno Therapeutics, Inc. | 2.02B | 2.57% | 1,538,574 | 190.41M |
| 96 | CLDX | Celldex Therapeutics, Inc. | 2.00B | -1.80% | 1,378,950 | 1.55M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.95B | -6.78% | 5,513,177 | 51.95M |
| 98 | RXRX | Recursion Pharmaceuticals, Inc. | 1.94B | -2.65% | 14,610,760 | 74.68M |
| 99 | NKTR | Nektar Therapeutics | 1.93B | 4.67% | 1,068,872 | 62.60M |
| 100 | SNDX | Syndax Pharmaceuticals, Inc. | 1.91B | 5.03% | 2,260,950 | 172.35M |
| 101 | OLMA | Olema Pharmaceuticals, Inc. | 1.90B | -0.78% | 1,491,147 | - |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.88B | 1.43% | 1,825,506 | 283.06M |
| 103 | PHVS | Pharvaris N.V. | 1.84B | 1.39% | 152,192 | - |
| 104 | RLAY | Relay Therapeutics, Inc. | 1.83B | 12.01% | 8,212,545 | 15.36M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 1.81B | -8.98% | 655,364 | - |
| 106 | VCEL | Vericel Corporation | 1.80B | -5.31% | 522,908 | 276.26M |
| 107 | RAPT | RAPT Therapeutics, Inc. | 1.79B | 0.03% | 902,488 | - |
| 108 | GLTO | Galecto, Inc. | 1.78B | -0.67% | 171,473 | - |
| 109 | TYRA | Tyra Biosciences, Inc. | 1.78B | 0.39% | 695,504 | - |
| 110 | AGIO | Agios Pharmaceuticals, Inc. | 1.77B | 0.83% | 764,333 | 54.03M |
| 111 | ELVN | Enliven Therapeutics, Inc. | 1.76B | 0.24% | 754,011 | - |
| 112 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -3.95% | 2,620,224 | 2.20B |
| 113 | ZYME | Zymeworks Inc. | 1.74B | -2.18% | 547,381 | 134.48M |
| 114 | DFTX | Definium Therapeutics, Inc. | 1.72B | 0.93% | 2,064,476 | - |
| 115 | INVA | Innoviva, Inc. | 1.72B | -2.46% | 1,101,830 | 411.33M |
| 116 | MANE | Veradermics, Incorporated | 1.71B | 6.85% | 279,377 | - |
| 117 | OCS | Oculis Holding AG | 1.70B | -1.93% | 213,971 | 992.00K |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.67B | 0.26% | 412,107 | - |
| 119 | KOD | Kodiak Sciences Inc. | 1.66B | -4.22% | 959,892 | - |
| 120 | NVAX | Novavax, Inc. | 1.65B | -9.38% | 10,229,166 | 1.12B |
| 121 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | -1.76% | 710,560 | 868.45M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.64B | -0.87% | 685,104 | 83.98M |
| 123 | IMCR | Immunocore Holdings plc | 1.64B | 0.81% | 550,993 | 400.02M |
| 124 | SION | Sionna Therapeutics, Inc. | 1.63B | -3.84% | 183,146 | - |
| 125 | GENB | Generate Biomedicines, Inc. | 1.61B | -20.94% | 6,218,836 | 31.89M |
| 126 | ARDX | Ardelyx, Inc. | 1.60B | -1.21% | 3,594,235 | 407.32M |
| 127 | IOVA | Iovance Biotherapeutics, Inc. | 1.60B | 1.85% | 19,051,875 | 263.50M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -3.50% | 3,236,096 | 67.67M |
| 129 | MBX | MBX Biosciences, Inc. | 1.53B | -7.11% | 1,170,157 | - |
| 130 | CRVS | Corvus Pharmaceuticals, Inc. | 1.53B | - | 647,262 | - |
| 131 | BHVN | Biohaven Ltd. | 1.53B | 3.32% | 2,919,427 | - |
| 132 | TRVI | Trevi Therapeutics, Inc. | 1.53B | 3.47% | 1,305,049 | - |
| 133 | ANAB | AnaptysBio, Inc. | 1.52B | -1.89% | 274,652 | 169.47M |
| 134 | TNGX | Tango Therapeutics, Inc. | 1.50B | -2.28% | 1,845,722 | 66.50M |
| 135 | SVRA | Savara Inc. | 1.49B | 0.84% | 2,320,577 | - |
| 136 | NBTX | Nanobiotix S.A. | 1.48B | 12.83% | 85,853 | 11.93M |
| 137 | EYPT | EyePoint, Inc. | 1.45B | -1.68% | 2,731,341 | 42.34M |
| 138 | CAPR | Capricor Therapeutics, Inc. | 1.44B | 0.14% | 1,433,378 | 11.13M |
| 139 | VIR | Vir Biotechnology, Inc. | 1.43B | -2.47% | 5,399,537 | 68.56M |
| 140 | ZBIO | Zenas BioPharma, Inc. | 1.41B | -0.04% | 466,379 | 15.00M |
| 141 | GLUE | Monte Rosa Therapeutics, Inc. | 1.41B | -4.05% | 1,972,111 | 181.54M |
| 142 | IMTX | Immatics N.V. | 1.39B | 2.07% | 390,188 | 99.45M |
| 143 | RAPP | Rapport Therapeutics, Inc. | 1.38B | -1.59% | 290,753 | - |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.35B | -0.37% | 841,151 | - |
| 145 | PGEN | Precigen, Inc. | 1.34B | -0.52% | 3,203,209 | 6.31M |
| 146 | ATAI | AtaiBeckley Inc. | 1.32B | -2.68% | 6,267,767 | 3.02M |
| 147 | SEPN | Septerna, Inc. | 1.30B | -4.16% | 412,053 | 22.05M |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.26B | -0.96% | 1,026,506 | - |
| 149 | DBVT | DBV Technologies S.A. | 1.25B | -2.46% | 372,483 | 5.50M |
| 150 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -0.88% | 4,302,007 | 6.31M |
| 151 | IVA | Inventiva S.A. | 1.24B | -0.92% | 180,240 | 19.93M |
| 152 | PHAR | Pharming Group N.V. | 1.13B | -0.43% | 10,203 | 362.27M |
| 153 | SANA | Sana Biotechnology, Inc. | 1.12B | -1.41% | 1,691,023 | - |
| 154 | DAWN | Day One Biopharmaceuticals, Inc. | 1.09B | -0.47% | 1,457,748 | 158.18M |
| 155 | ABCL | AbCellera Biologics Inc. | 1.09B | 0.56% | 5,381,263 | 75.13M |
| 156 | INBX | Inhibrx Biosciences, Inc. | 1.08B | -4.01% | 228,970 | 1.40M |
| 157 | GERN | Geron Corporation | 1.07B | 1.82% | 11,297,209 | 183.88M |
| 158 | BCAX | Bicara Therapeutics Inc. | 1.06B | -0.12% | 682,224 | - |
| 159 | AKTS | Aktis Oncology, Inc. | 1.06B | 2.55% | 186,861 | 5.56M |
| 160 | URGN | UroGen Pharma Ltd. | 1.02B | 2.46% | 1,531,354 | 96.52M |
| 161 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | -9.20% | 5,900,077 | 266.14M |
| 162 | MNKD | MannKind Corporation | 1.01B | 1.23% | 8,891,055 | 348.97M |
| 163 | CMPX | Compass Therapeutics, Inc. | 1.00B | -2.25% | 3,696,999 | 850.00K |
| 164 | VTYX | Ventyx Biosciences, Inc. | 1.00B | - | 19,119,728 | - |
| 165 | FTRE | Fortrea Holdings Inc. | 997.10M | -0.74% | 2,608,235 | 2.72B |
| 166 | PHAT | Phathom Pharmaceuticals, Inc. | 989.71M | -7.37% | 1,181,634 | 175.11M |
| 167 | QURE | uniQure N.V. | 973.62M | -8.70% | 5,986,073 | 15.75M |
| 168 | VALN | Valneva SE | 971.11M | 1.37% | 6,963 | 211.09M |
| 169 | AVBP | ArriVent BioPharma, Inc. | 948.23M | -1.12% | 318,116 | - |
| 170 | XNCR | Xencor, Inc. | 936.53M | -5.76% | 874,792 | 125.58M |
| 171 | SGP | SpyGlass Pharma, Inc. | 932.89M | -1.23% | 44,674 | - |
| 172 | TBPH | Theravance Biopharma, Inc. | 924.77M | 0.33% | 1,354,217 | 80.33M |
| 173 | GHRS | GH Research PLC | 921.14M | -4.99% | 195,316 | - |
| 174 | SPRY | ARS Pharmaceuticals, Inc. | 917.32M | -0.64% | 660,760 | 142.77M |
| 175 | CGEM | Cullinan Therapeutics, Inc. | 915.68M | 1.91% | 1,655,054 | - |
| 176 | MRVI | Maravai LifeSciences Holdings, Inc. | 911.59M | - | 1,369,303 | 185.74M |
| 177 | CTMX | CytomX Therapeutics, Inc. | 909.87M | -2.01% | 2,882,456 | 113.63M |
| 178 | ABUS | Arbutus Biopharma Corporation | 896.23M | -0.85% | 2,138,355 | 14.61M |
| 179 | OMER | Omeros Corporation | 854.35M | 4.33% | 1,205,847 | - |
| 180 | ARVN | Arvinas, Inc. | 848.76M | -0.82% | 882,666 | 262.60M |
| 181 | SLS | SELLAS Life Sciences Group, Inc. | 839.49M | 0.20% | 11,422,173 | - |
| 182 | ANNX | Annexon, Inc. | 834.71M | 4.09% | 4,702,564 | - |
| 183 | JANX | Janux Therapeutics, Inc. | 827.92M | -1.38% | 861,162 | 10.00M |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 822.89M | 3.30% | 590,092 | 1.43M |
| 185 | EVMN | Evommune, Inc. | 819.63M | -2.37% | 324,141 | 13.00M |
| 186 | PRME | Prime Medicine, Inc. | 817.92M | 5.48% | 5,728,118 | 5.98M |
| 187 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 802.29M | -2.15% | 167,812 | - |
| 188 | DRUG | Bright Minds Biosciences Inc. | 796.87M | -1.96% | 54,607 | - |
| 189 | AGMB | AgomAb Therapeutics NV | 780.76M | 0.06% | 89,505 | - |
| 190 | KURA | Kura Oncology, Inc. | 759.66M | 0.92% | 1,257,007 | 104.03M |
| 191 | MPLT | MapLight Therapeutics, Inc. | 753.69M | -0.86% | 119,870 | - |
| 192 | GYRE | Gyre Therapeutics, Inc. | 748.94M | -3.29% | 80,999 | 107.27M |
| 193 | EIKN | Eikon Therapeutics, Inc. | 743.90M | 1.03% | 270,804 | - |
| 194 | MDXG | MiMedx Group, Inc. | 727.98M | -1.01% | 1,826,120 | 418.63M |
| 195 | JBIO | Jade Biosciences, Inc. | 682.24M | 1.85% | 425,134 | - |
| 196 | ENGN | enGene Holdings Inc. | 677.26M | 0.80% | 58,424 | - |
| 197 | PROK | ProKidney Corp. | 673.87M | 0.45% | 395,770 | 744.00K |
| 198 | DRTS | Alpha Tau Medical Ltd. | 661.65M | -2.14% | 210,381 | - |
| 199 | VOR | Vor Biopharma Inc. | 641.07M | -2.89% | 432,526 | - |
| 200 | REPL | Replimune Group, Inc. | 631.68M | -0.52% | 1,231,123 | - |
| 201 | RIGL | Rigel Pharmaceuticals, Inc. | 630.58M | -2.72% | 261,181 | 282.08M |
| 202 | ZURA | Zura Bio Limited | 628.08M | -2.22% | 406,177 | - |
| 203 | LXRX | Lexicon Pharmaceuticals, Inc. | 627.81M | -2.00% | 1,257,443 | 70.86M |
| 204 | ALLO | Allogene Therapeutics, Inc. | 624.75M | 1.83% | 8,333,376 | 22.00K |
| 205 | ANRO | Alto Neuroscience, Inc. | 611.70M | 2.07% | 91,613 | - |
| 206 | MGTX | MeiraGTx Holdings plc | 608.51M | -1.31% | 216,856 | 27.42M |
| 207 | LBRX | LB Pharmaceuticals Inc | 605.15M | -0.91% | 103,404 | - |
| 208 | YDES | YD Bio Limited | 603.34M | -4.98% | 12,960 | 510.36K |
| 209 | OCGN | Ocugen, Inc. | 596.76M | -2.67% | 7,884,973 | 5.37M |
| 210 | DSGN | Design Therapeutics, Inc. | 593.56M | -2.25% | 115,673 | - |
| 211 | NMRA | Neumora Therapeutics, Inc. | 593.09M | -1.69% | 547,189 | - |
| 212 | CRMD | CorMedix Inc. | 561.77M | -2.99% | 1,395,758 | 214.30M |
| 213 | LRMR | Larimar Therapeutics, Inc. | 560.68M | -3.80% | 4,298,930 | - |
| 214 | CTNM | Contineum Therapeutics, Inc. | 560.36M | -2.79% | 213,520 | - |
| 215 | FULC | Fulcrum Therapeutics, Inc. | 558.11M | -4.01% | 759,518 | 80.00M |
| 216 | RCKT | Rocket Pharmaceuticals, Inc. | 542.19M | 10.60% | 6,789,535 | - |
| 217 | ALT | Altimmune, Inc. | 539.75M | -3.36% | 3,014,520 | 20.00K |
| 218 | FBRX | Forte Biosciences, Inc. | 538.87M | 3.28% | 150,362 | - |
| 219 | VNDA | Vanda Pharmaceuticals Inc. | 526.65M | 3.60% | 2,614,888 | 216.11M |
| 220 | LXEO | Lexeo Therapeutics, Inc. | 524.78M | 4.06% | 799,813 | - |
| 221 | LYEL | Lyell Immunopharma, Inc. | 509.85M | 4.30% | 85,673 | 41.00K |
| 222 | ADCT | ADC Therapeutics SA | 507.90M | -0.73% | 553,910 | 75.21M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 502.74M | -1.76% | 421,801 | 84.39M |
| 224 | FDMT | 4D Molecular Therapeutics, Inc. | 492.74M | - | 744,114 | 120.00K |
| 225 | EPRX | Eupraxia Pharmaceuticals Inc. | 491.18M | - | 95,501 | - |
| 226 | TENX | Tenax Therapeutics, Inc. | 486.84M | 2.13% | 944,984 | - |
| 227 | SLDB | Solid Biosciences Inc. | 483.82M | -1.27% | 908,002 | - |
| 228 | IVVD | Invivyd, Inc. | 477.97M | -0.59% | 1,003,523 | 50.04M |
| 229 | VTVT | vTv Therapeutics Inc. | 473.52M | -2.95% | 46,127 | 17.00K |
| 230 | ASMB | Assembly Biosciences, Inc. | 471.98M | 0.84% | 129,775 | 37.19M |
| 231 | KYTX | Kyverna Therapeutics, Inc. | 469.03M | 1.11% | 453,185 | - |
| 232 | PRTA | Prothena Corporation plc | 466.73M | 0.35% | 439,306 | 9.68M |
| 233 | LCTX | Lineage Cell Therapeutics, Inc. | 465.27M | -2.04% | 774,617 | 10.82M |
| 234 | RGNX | REGENXBIO Inc. | 457.63M | 3.31% | 811,874 | 161.32M |
| 235 | AUTL | Autolus Therapeutics plc | 455.11M | -3.39% | 1,517,766 | 51.13M |
| 236 | VSTM | Verastem, Inc. | 441.48M | - | 851,953 | 13.38M |
| 237 | TECX | Tectonic Therapeutic, Inc. | 438.90M | -2.01% | 225,701 | - |
| 238 | KROS | Keros Therapeutics, Inc. | 432.31M | -5.59% | 349,610 | 246.72M |
| 239 | TRDA | Entrada Therapeutics, Inc. | 427.83M | -6.72% | 304,285 | 25.42M |
| 240 | PEPG | PepGen Inc. | 427.61M | -0.32% | 194,197 | - |
| 241 | DMAC | DiaMedica Therapeutics Inc. | 425.95M | -3.40% | 268,608 | - |
| 242 | IMMX | Immix Biopharma, Inc. | 424.73M | -4.95% | 571,089 | - |
| 243 | LENZ | LENZ Therapeutics, Inc. | 422.10M | -0.22% | 540,859 | 17.50M |
| 244 | IPSC | Century Therapeutics, Inc. | 416.78M | 3.57% | 742,216 | 113.34M |
| 245 | UPB | Upstream Bio, Inc. | 415.02M | -2.78% | 1,435,876 | 2.80M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 414.98M | -0.76% | 115,324 | 66.98M |
| 247 | ABSI | Absci Corporation | 412.02M | -2.49% | 2,023,275 | 2.82M |
| 248 | AVXL | Anavex Life Sciences Corp. | 410.54M | -0.67% | 2,384,590 | - |
| 249 | NAGE | Niagen Bioscience, Inc. | 404.45M | -2.51% | 1,961,911 | 124.71M |
| 250 | IMMP | Immutep Limited | 404.21M | 2.19% | 299,126 | 5.28M |
| 251 | PRTC | PureTech Health plc | 399.43M | 0.72% | 920 | 6.39M |
| 252 | BCYC | Bicycle Therapeutics plc | 397.48M | 1.60% | 238,741 | 28.34M |
| 253 | ARMP | Armata Pharmaceuticals, Inc. | 391.74M | -0.65% | 33,287 | 5.05M |
| 254 | CADL | Candel Therapeutics, Inc. | 384.55M | 1.94% | 2,102,487 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 384.05M | -1.42% | 118,596 | - |
| 256 | DNA | Ginkgo Bioworks Holdings, Inc. | 380.52M | -30.48% | 3,908,250 | 170.16M |
| 257 | NBP | NovaBridge Biosciences | 378.15M | - | 901,001 | - |
| 258 | AURA | Aura Biosciences, Inc. | 374.67M | -1.51% | 165,496 | - |
| 259 | BNTC | Benitec Biopharma Inc. | 373.38M | -2.59% | 88,981 | - |
| 260 | HELP | Cybin Inc. | 367.76M | -5.28% | 337,725 | - |
| 261 | MNPR | Monopar Therapeutics Inc. | 367.48M | 0.27% | 113,167 | - |
| 262 | AVIR | Atea Pharmaceuticals, Inc. | 365.63M | - | 364,199 | - |
| 263 | NGNE | Neurogene Inc. | 363.86M | 19.36% | 1,259,819 | 925.00K |
| 264 | CLYM | Climb Bio, Inc. | 342.09M | -3.12% | 582,313 | - |
| 265 | TARA | Protara Therapeutics, Inc. | 340.81M | 10.23% | 1,332,718 | - |
| 266 | STRO | Sutro Biopharma, Inc. | 335.46M | - | 94,617 | 105.65M |
| 267 | RLMD | Relmada Therapeutics, Inc. | 334.40M | -0.87% | 276,663 | - |
| 268 | RZLT | Rezolute, Inc. | 333.43M | -2.43% | 2,488,246 | - |
| 269 | FHTX | Foghorn Therapeutics Inc. | 332.74M | -1.39% | 83,648 | 24.52M |
| 270 | ALDX | Aldeyra Therapeutics, Inc. | 328.49M | -0.73% | 1,015,863 | - |
| 271 | AVTX | Avalo Therapeutics, Inc. | 323.97M | -0.79% | 1,015,844 | 192.00K |
| 272 | IMRX | Immuneering Corporation | 322.20M | - | 812,881 | - |
| 273 | CABA | Cabaletta Bio, Inc. | 319.60M | -4.60% | 2,886,729 | - |
| 274 | XOMA | XOMA Royalty Corporation | 316.14M | -4.60% | 163,983 | 47.11M |
| 275 | ACRS | Aclaris Therapeutics, Inc. | 310.95M | -8.31% | 1,726,982 | 7.83M |
| 276 | NAUT | Nautilus Biotechnology, Inc. | 305.66M | - | 139,242 | - |
| 277 | XFOR | X4 Pharmaceuticals, Inc. | 300.78M | 5.85% | 793,190 | 33.98M |
| 278 | CLLS | Cellectis S.A. | 294.41M | -3.48% | 23,538 | 82.55M |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 289.96M | -1.39% | 119,830 | 38.79M |
| 280 | ACIU | AC Immune SA | 289.90M | -1.01% | 237,473 | 5.48M |
| 281 | ANL | Adlai Nortye Ltd. | 288.93M | -14.47% | 382,010 | -1.35M |
| 282 | PBYI | Puma Biotechnology, Inc. | 287.23M | -25.00% | 1,664,965 | 228.37M |
| 283 | IRD | Opus Genetics, Inc. | 286.89M | 15.88% | 1,231,702 | 14.63M |
| 284 | NERV | Minerva Neurosciences, Inc. | 285.61M | 5.94% | 83,726 | - |
| 285 | IKT | Inhibikase Therapeutics, Inc. | 280.40M | -1.91% | 1,260,869 | 1.00 |
| 286 | ABEO | Abeona Therapeutics Inc. | 277.46M | -1.54% | 591,063 | 400.00K |
| 287 | ALXO | ALX Oncology Holdings Inc. | 276.83M | -10.21% | 1,008,938 | - |
| 288 | ENLV | Enlivex Ltd. | 272.99M | - | 161,792 | - |
| 289 | AARD | Aardvark Therapeutics, Inc. | 271.73M | -0.08% | 531,140 | - |
| 290 | ALEC | Alector, Inc. | 267.97M | -5.08% | 1,337,610 | 21.05M |
| 291 | PALI | Palisade Bio, Inc. | 263.74M | -4.32% | 1,856,894 | - |
| 292 | CCCC | C4 Therapeutics, Inc. | 261.67M | -2.88% | 3,465,323 | 35.95M |
| 293 | SLN | Silence Therapeutics plc | 256.95M | 0.37% | 149,047 | 25.83M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 255.40M | 2.84% | 15,276 | 18.97M |
| 295 | CHRS | Coherus Oncology, Inc. | 250.36M | -1.18% | 1,038,993 | 277.73M |
| 296 | CBUS | Cibus, Inc. | 249.28M | 4.83% | 432,377 | 3.79M |
| 297 | STTK | Shattuck Labs, Inc. | 248.06M | -2.97% | 282,375 | 1.00M |
| 298 | OABI | OmniAb, Inc. | 247.60M | -4.44% | 242,319 | 21.09M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 247.32M | 1.15% | 103,613 | 2.82M |
| 300 | ACHV | Achieve Life Sciences, Inc. | 243.28M | -3.59% | 269,506 | - |
| 301 | SRZN | Surrozen, Inc. | 238.29M | 7.96% | 47,056 | 3.60M |
| 302 | CBIO | Crescent Biopharma, Inc. | 236.36M | -2.11% | 136,931 | 10.84M |
| 303 | NVCT | Nuvectis Pharma, Inc. | 234.72M | -0.89% | 54,374 | - |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 234.28M | -1.08% | 317,177 | 97.60M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 232.95M | - | 25,597 | 3.80M |
| 306 | PLX | Protalix BioTherapeutics, Inc. | 231.61M | -4.32% | 1,487,354 | 61.84M |
| 307 | VYGR | Voyager Therapeutics, Inc. | 227.96M | -3.07% | 831,007 | 31.32M |
| 308 | PRLD | Prelude Therapeutics Incorporated | 227.42M | -3.83% | 96,053 | 10.50M |
| 309 | ELTX | Elicio Therapeutics, Inc. | 227.00M | 10.65% | 206,376 | - |
| 310 | MDWD | MediWound Ltd. | 221.70M | -1.26% | 75,852 | 20.93M |
| 311 | HRTX | Heron Therapeutics, Inc. | 218.20M | -0.83% | 2,155,553 | 154.90M |
| 312 | HUMA | Humacyte, Inc. | 215.19M | -9.35% | 4,246,417 | 1.57M |
| 313 | EDIT | Editas Medicine, Inc. | 214.76M | 0.92% | 1,946,767 | 46.38M |
| 314 | OVID | Ovid Therapeutics Inc. | 212.20M | -1.21% | 582,566 | 6.61M |
| 315 | PMN | ProMIS Neurosciences, Inc. | 210.83M | 12.70% | 108,035 | - |
| 316 | ELDN | Eledon Pharmaceuticals, Inc. | 207.90M | 8.26% | 1,190,862 | - |
| 317 | CNTX | Context Therapeutics Inc. | 206.73M | -1.32% | 305,748 | - |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 200.42M | 1.00% | 337,867 | - |
| 319 | NTHI | NeOnc Technologies Holdings, Inc. | 199.03M | 1.29% | 21,379 | 59.99K |
| 320 | RNAC | Cartesian Therapeutics, Inc. | 197.37M | -9.10% | 176,783 | 1.09M |
| 321 | KLRS | Kalaris Therapeutics, Inc. | 195.63M | -0.95% | 27,103 | - |
| 322 | SABS | SAB Biotherapeutics, Inc. | 195.19M | -0.73% | 401,873 | 114.70K |
| 323 | GALT | Galectin Therapeutics Inc. | 192.13M | -5.10% | 530,436 | - |
| 324 | NKTX | Nkarta, Inc. | 191.78M | 3.05% | 677,923 | - |
| 325 | ABOS | Acumen Pharmaceuticals, Inc. | 190.20M | 10.95% | 853,187 | - |
| 326 | MOLN | Molecular Partners AG | 188.23M | 2.92% | 5,976 | 856.30K |
| 327 | VXRT | Vaxart, Inc. | 187.99M | 4.31% | - | 148.20M |
| 328 | SGMT | Sagimet Biosciences Inc. | 185.70M | -2.73% | 315,662 | - |
| 329 | TLSA | Tiziana Life Sciences Ltd | 185.05M | -0.68% | 90,057 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.73M | -3.19% | 355,618 | 10.30M |
| 331 | CRBU | Caribou Biosciences, Inc. | 177.59M | -4.52% | 1,371,520 | 9.30M |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 173.71M | -0.58% | 1,129,332 | - |
| 333 | KPTI | Karyopharm Therapeutics Inc. | 172.62M | 0.64% | 529,894 | 146.07M |
| 334 | FATE | Fate Therapeutics, Inc. | 170.72M | -5.13% | 1,596,620 | 6.65M |
| 335 | CGEN | Compugen Ltd. | 169.30M | 1.12% | 334,231 | 6.90M |
| 336 | PRQR | ProQR Therapeutics N.V. | 167.50M | - | 367,223 | 18.86M |
| 337 | RANI | Rani Therapeutics Holdings, Inc. | 166.48M | -0.72% | 633,416 | 1.20M |
| 338 | WHWK | Whitehawk Therapeutics, Inc. | 165.42M | 8.00% | 262,943 | 14.38M |
| 339 | MENS | Jyong Biotech Ltd. | 165.34M | -6.96% | 268,671 | - |
| 340 | IPHA | Innate Pharma S.A. | 162.13M | -1.44% | 14,952 | 14.84M |
| 341 | SGMO | Sangamo Therapeutics, Inc. | 160.68M | -1.75% | 3,019,084 | 32.88M |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 158.79M | 3.88% | 308,328 | - |
| 343 | ZNTL | Zentalis Pharmaceuticals, Inc. | 154.75M | -3.24% | 496,693 | 26.87M |
| 344 | UNCY | Unicycive Therapeutics, Inc. | 148.94M | 1.32% | 479,423 | - |
| 345 | PLYX | Polaryx Therapeutics, Inc. | 144.40M | -4.39% | 279,292 | - |
| 346 | ARTV | Artiva Biotherapeutics, Inc. | 142.85M | 6.79% | 241,877 | 251.00K |
| 347 | BDTX | Black Diamond Therapeutics, Inc. | 140.73M | -1.20% | 374,153 | 70.00M |
| 348 | ADAG | Adagene Inc. | 139.51M | -4.67% | 118,082 | 103.20K |
| 349 | CNTB | Connect Biopharma Holdings Limited | 138.08M | -1.98% | 92,214 | 762.00K |
| 350 | ORMP | Oramed Pharmaceuticals Inc. | 135.93M | -0.44% | 108,724 | 2.00M |
| 351 | IMUX | Immunic, Inc. | 133.07M | 7.63% | 3,783,718 | - |
| 352 | CRDF | Cardiff Oncology, Inc. | 132.63M | -1.02% | 858,477 | 593.00K |
| 353 | GNLX | Genelux Corporation | 131.97M | 3.11% | 166,961 | 8.00K |
| 354 | ACOG | Alpha Cognition Inc. | 130.45M | - | 56,716 | 7.43M |
| 355 | MGNX | MacroGenics, Inc. | 125.88M | 0.51% | 540,943 | 127.63M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 124.35M | 1.12% | 352,967 | 182.34K |
| 357 | SPRO | Spero Therapeutics, Inc. | 122.26M | -1.81% | 289,965 | 40.55M |
| 358 | TNYA | Tenaya Therapeutics, Inc. | 121.63M | -7.77% | 2,666,094 | - |
| 359 | ONCY | Oncolytics Biotech Inc. | 121.60M | 5.61% | 1,200,905 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 116.30M | -0.40% | 82,020 | 3.99M |
| 361 | KRRO | Korro Bio, Inc. | 114.23M | 0.25% | 100,911 | 7.37M |
| 362 | AGEN | Agenus Inc. | 113.25M | -0.89% | 223,996 | 106.83M |
| 363 | EQ | Equillium, Inc. | 110.83M | 4.90% | 273,284 | 4.39M |
| 364 | SAVA | Cassava Sciences, Inc. | 110.14M | -2.98% | 286,730 | - |
| 365 | FBIO | Fortress Biotech, Inc. | 106.15M | -2.84% | 441,507 | 62.30M |
| 366 | TTRX | Turn Therapeutics Inc. | 106.00M | -6.25% | 9,323 | - |
| 367 | DTIL | Precision BioSciences, Inc. | 101.10M | 5.26% | 167,102 | 698.00K |
| 368 | HURA | TuHURA Biosciences, Inc. | 101.10M | 3.09% | 1,393,428 | - |
| 369 | GANX | Gain Therapeutics, Inc. | 100.58M | 5.24% | 501,990 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 99.30M | -1.97% | 95,254 | - |
| 371 | GOSS | Gossamer Bio, Inc. | 98.35M | 5.70% | 27,492,070 | 44.05M |
| 372 | VANI | Vivani Medical, Inc. | 98.22M | -1.60% | 101,805 | - |
| 373 | IBIO | iBio, Inc. | 97.41M | -8.14% | 1,396,790 | 300.00K |
| 374 | BMEA | Biomea Fusion, Inc. | 96.86M | -5.52% | 1,163,281 | - |
| 375 | SEER | Seer, Inc. | 96.75M | -17.31% | 831,258 | 16.58M |
| 376 | CGTX | Cognition Therapeutics, Inc. | 96.22M | -6.03% | 567,628 | - |
| 377 | DWTX | Dogwood Therapeutics, Inc. | 94.89M | 3.26% | 8,898 | - |
| 378 | ATYR | aTyr Pharma, Inc. | 93.73M | -3.05% | 932,632 | 190.00K |
| 379 | KZIA | Kazia Therapeutics Limited | 92.07M | -4.52% | 159,381 | 1.20M |
| 380 | PYXS | Pyxis Oncology, Inc. | 91.53M | -3.29% | 138,387 | 2.82M |
| 381 | CDXS | Codexis, Inc. | 91.23M | -5.61% | 1,238,027 | 52.93M |
| 382 | PMVP | PMV Pharmaceuticals, Inc. | 90.46M | 24.09% | 3,803,892 | - |
| 383 | OKYO | OKYO Pharma Limited | 87.84M | -0.58% | 119,808 | - |
| 384 | VRCA | Verrica Pharmaceuticals Inc. | 87.46M | - | 66,957 | 30.83M |
| 385 | ACTU | Actuate Therapeutics, Inc. | 86.93M | -5.32% | 24,044 | - |
| 386 | MAIA | MAIA Biotechnology, Inc. | 86.48M | 3.67% | 878,721 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 85.29M | 14.61% | 19,333 | 7.41M |
| 388 | CSBR | Champions Oncology, Inc. | 82.69M | -0.58% | 1,920 | 58.42M |
| 389 | PLRX | Pliant Therapeutics, Inc. | 79.88M | 0.78% | 509,720 | - |
| 390 | MCRB | Seres Therapeutics, Inc. | 79.07M | -1.58% | 32,521 | 351.00K |
| 391 | PYPD | PolyPid Ltd. | 77.37M | 0.71% | 40,426 | - |
| 392 | EXOZ | eXoZymes, Inc. | 74.34M | -0.56% | 927 | -700.00 |
| 393 | ACET | Adicet Bio, Inc. | 73.27M | -0.96% | 41,835 | - |
| 394 | GUTS | Fractyl Health, Inc. | 71.98M | -1.14% | 1,839,611 | 3.00K |
| 395 | IMA | ImageneBio, Inc. | 71.57M | -1.61% | 9,806 | 800.00K |
| 396 | MNOV | MediciNova, Inc. | 71.37M | -4.61% | 55,092 | 409.66K |
| 397 | ANVS | Annovis Bio, Inc. | 71.03M | -3.25% | 262,386 | - |
| 398 | XBIT | XBiotech Inc. | 68.90M | -3.83% | 71,291 | - |
| 399 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.36M | -2.39% | 13,861 | 501.00K |
| 400 | ETHZ | ETHZilla Corporation | 67.11M | -7.59% | 428,152 | 4.11M |
| 401 | GRCE | Grace Therapeutics, Inc. | 66.38M | 4.13% | 150,577 | - |
| 402 | CING | Cingulate Inc. | 65.32M | -3.39% | 348,724 | - |
| 403 | NRXS | NeurAxis, Inc. | 63.92M | 5.45% | 261,547 | 3.36M |
| 404 | ENTX | Entera Bio Ltd. | 63.74M | -7.95% | 118,371 | 124.00K |
| 405 | QTTB | Q32 Bio Inc. | 63.71M | -4.20% | 203,789 | - |
| 406 | IFRX | InflaRx N.V. | 62.33M | -1.21% | 100,928 | 73.73K |
| 407 | ATHE | Alterity Therapeutics Limited | 61.98M | -2.55% | 16,852 | 4.96M |
| 408 | TIL | Instil Bio, Inc. | 60.36M | -1.00% | 31,059 | - |
| 409 | TCRX | TScan Therapeutics, Inc. | 60.15M | -4.50% | 404,083 | 8.42M |
| 410 | ICCC | ImmuCell Corporation | 59.43M | 0.31% | 3,272 | 27.77M |
| 411 | NRXP | NRx Pharmaceuticals, Inc. | 59.28M | -3.63% | 415,400 | 242.00K |
| 412 | MREO | Mereo BioPharma Group plc | 58.97M | -3.99% | 1,810,642 | 500.00K |
| 413 | SPRB | Spruce Biosciences, Inc. | 58.81M | -6.17% | 15,600 | 697.00K |
| 414 | RADX | Radiopharm Theranostics Limited | 58.07M | 0.20% | 21,448 | 8.20M |
| 415 | MGX | Metagenomi Therapeutics, Inc. | 57.07M | -5.00% | 235,856 | 30.91M |
| 416 | BYSI | BeyondSpring Inc. | 55.52M | 3.85% | 20,934 | 1.88M |
| 417 | LPCN | Lipocine Inc. | 55.30M | -0.40% | 326,950 | 4.32M |
| 418 | NTRB | Nutriband Inc. | 53.97M | 3.02% | 5,906 | 2.28M |
| 419 | PSTV | Plus Therapeutics, Inc. | 53.55M | -6.66% | 5,288,136 | 5.26M |
| 420 | TVGN | Tevogen Bio Holdings Inc. | 53.24M | -8.71% | 1,505,881 | - |
| 421 | HYFT | MindWalk Holdings Corp. | 52.76M | -5.04% | 286,933 | 19.02M |
| 422 | LONA | LeonaBio, Inc. | 52.56M | 0.18% | 26,160 | - |
| 423 | OSTX | OS Therapies Incorporated | 51.77M | 2.80% | 217,751 | - |
| 424 | INKT | MiNK Therapeutics, Inc. | 51.40M | -0.73% | 4,775 | - |
| 425 | ESLA | Estrella Immunopharma, Inc. | 51.28M | 1.67% | 31,265 | - |
| 426 | KZR | Kezar Life Sciences, Inc. | 49.07M | - | 12,233 | - |
| 427 | ACRV | Acrivon Therapeutics, Inc. | 47.96M | -17.93% | 1,893,378 | - |
| 428 | IBO | Impact BioMedical Inc. | 45.54M | 0.07% | 45,993 | 25.00K |
| 429 | NXTC | NextCure, Inc. | 44.59M | -2.15% | 24,542 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | -3.05% | 60,267 | - |
| 431 | APLM | Apollomics, Inc. | 43.37M | -0.88% | 1,835 | 6.93M |
| 432 | ALGS | Aligos Therapeutics, Inc. | 43.26M | -6.27% | 21,906 | 2.65M |
| 433 | VERU | Veru Inc. | 41.41M | -3.01% | 32,214 | 16.89M |
| 434 | LITS | Lite Strategy, Inc. | 41.09M | -0.88% | 229,328 | - |
| 435 | RLYB | Rallybio Corporation | 39.81M | 10.88% | 103,757 | 674.00K |
| 436 | KLTO | Klotho Neurosciences, Inc. | 39.09M | 11.21% | 13,095,285 | - |
| 437 | ATRA | Atara Biotherapeutics, Inc. | 39.08M | 3.04% | 130,720 | 151.93M |
| 438 | XLO | Xilio Therapeutics, Inc. | 38.81M | -1.57% | 975,937 | 31.80M |
| 439 | JSPR | Jasper Therapeutics, Inc. | 38.62M | 0.73% | 175,083 | - |
| 440 | SNSE | Sensei Biotherapeutics, Inc. | 38.60M | 0.93% | 127,846 | - |
| 441 | ATOS | Atossa Therapeutics, Inc. | 38.15M | -0.89% | 69,226 | - |
| 442 | NBY | NovaBay Pharmaceuticals, Inc. | 37.62M | -5.88% | 261,510 | 10.30M |
| 443 | TVRD | Tvardi Therapeutics, Inc. | 37.43M | -1.48% | 42,144 | - |
| 444 | PDSB | PDS Biotechnology Corporation | 36.94M | -3.47% | 275,932 | - |
| 445 | CRVO | CervoMed Inc. | 36.92M | -9.32% | 299,870 | 6.16M |
| 446 | ATNM | Actinium Pharmaceuticals, Inc. | 36.81M | 2.61% | 107,678 | 90.00K |
| 447 | OKUR | OnKure Therapeutics, Inc. | 36.72M | 1.88% | 143,409 | - |
| 448 | PLUR | Pluri Inc. | 36.18M | -1.91% | 2,417 | 1.34M |
| 449 | LSTA | Lisata Therapeutics, Inc. | 36.17M | -7.03% | 103,943 | 1.07M |
| 450 | CELU | Celularity Inc. | 35.47M | -0.81% | 18,339 | 40.58M |
| 451 | PTN | Palatin Technologies, Inc. | 35.46M | -0.43% | 5,459 | 8.96M |
| 452 | OTLK | Outlook Therapeutics, Inc. | 34.95M | -2.91% | 799,603 | 205.70K |
| 453 | CVM | CEL-SCI Corporation | 34.48M | -6.58% | 107,410 | - |
| 454 | INMB | INmune Bio Inc. | 34.29M | -3.73% | 607,989 | 50.00K |
| 455 | RNXT | RenovoRx, Inc. | 32.36M | 2.08% | 511,224 | 928.00K |
| 456 | ABVC | ABVC BioPharma, Inc. | 32.35M | 1.55% | 83,467 | 797.92K |
| 457 | LTRN | Lantern Pharma Inc. | 31.54M | -0.70% | 73,842 | - |
| 458 | TPST | Tempest Therapeutics, Inc. | 30.74M | -0.44% | 24,285 | - |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 30.35M | 0.79% | 40,993 | - |
| 460 | ANTX | AN2 Therapeutics, Inc. | 30.14M | 3.77% | 45,791 | - |
| 461 | RNTX | Rein Therapeutics Inc. | 29.97M | -5.00% | 225,698 | - |
| 462 | HOWL | Werewolf Therapeutics, Inc. | 29.13M | -5.02% | 429,986 | 1.14M |
| 463 | PASG | Passage Bio, Inc. | 28.99M | 5.31% | 17,042 | - |
| 464 | AEON | AEON Biopharma, Inc. | 28.34M | 2.75% | 72,057 | - |
| 465 | DYAI | Dyadic International, Inc. | 28.19M | -0.15% | 73,479 | 3.34M |
| 466 | KYNB | Kyntra Bio, Inc. | 28.03M | -1.29% | 43,976 | 8.30M |
| 467 | BCTX | BriaCell Therapeutics Corp. | 27.70M | -4.50% | 178,664 | - |
| 468 | EVAX | Evaxion A/S | 26.61M | -1.85% | 9,399 | 7.65M |
| 469 | IGC | IGC Pharma, Inc. | 26.57M | -2.63% | 152,560 | 1.11M |
| 470 | BOLD | Boundless Bio, Inc. | 25.97M | - | 90,254 | - |
| 471 | CUE | Cue Biopharma, Inc. | 25.56M | -2.71% | 169,421 | 7.10M |
| 472 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.18M | -0.69% | 36,220 | - |
| 473 | IOBT | IO Biotech, Inc. | 25.11M | -2.79% | 477,457 | - |
| 474 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 25.09M | 7.35% | 2,646,008 | - |
| 475 | SNTI | Senti Biosciences, Inc. | 24.82M | -3.78% | 84,173 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 24.68M | -6.33% | 65,589 | 4.69M |
| 477 | DARE | Daré Bioscience, Inc. | 24.29M | 1.80% | 74,182 | -57.13K |
| 478 | SKYE | Skye Bioscience, Inc. | 23.88M | -3.39% | 142,019 | - |
| 479 | XCUR | Exicure, Inc. | 23.84M | 0.81% | 7,883 | 500.00K |
| 480 | BRNS | Barinthus Biotherapeutics plc | 23.80M | 0.19% | 996 | 14.97M |
| 481 | HYPD | Hyperion DeFi, Inc. | 23.68M | -9.62% | 331,646 | 345.32K |
| 482 | VTGN | Vistagen Therapeutics, Inc. | 23.22M | -3.14% | 511,405 | 789.00K |
| 483 | GNTA | Genenta Science S.p.A. | 23.21M | 3.19% | 44,554 | - |
| 484 | NNVC | NanoViricides, Inc. | 22.67M | 5.00% | 208,575 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 22.37M | -4.82% | 42,127 | 14.99M |
| 486 | FBLG | FibroBiologics, Inc. | 22.21M | 16.15% | 1,288,706 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 20.36M | 5.24% | 93,583 | - |
| 488 | VYNE | VYNE Therapeutics Inc. | 19.99M | 1.13% | 415,327 | 524.00K |
| 489 | PLRZ | Polyrizon Ltd. | 19.91M | -5.04% | 50,548 | - |
| 490 | CVKD | Cadrenal Therapeutics, Inc. | 19.85M | 1.31% | 44,131 | - |
| 491 | SER | Serina Therapeutics, Inc. | 19.41M | -0.55% | 36,024 | 116.00K |
| 492 | INTS | Intensity Therapeutics, Inc. | 19.41M | -1.79% | 69,542 | - |
| 493 | BCAB | BioAtla, Inc. | 18.37M | 4.21% | 3,085,316 | 11.00M |
| 494 | EDSA | Edesa Biotech, Inc. | 18.37M | 41.94% | 43,239,390 | - |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 18.25M | -6.58% | 55,614 | - |
| 496 | LEXX | Lexaria Bioscience Corp. | 17.40M | -2.71% | 71,210 | 522.00K |
| 497 | INAB | IN8bio, Inc. | 16.60M | -0.58% | 43,016 | - |
| 498 | CTXR | Citius Pharmaceuticals, Inc. | 16.56M | -1.88% | 153,407 | 3.94M |
| 499 | HOTH | Hoth Therapeutics, Inc. | 15.67M | -2.88% | 289,324 | - |
| 500 | CRIS | Curis, Inc. | 15.61M | 2.70% | 133,297 | 11.65M |
| 501 | ALLR | Allarity Therapeutics, Inc. | 15.60M | -2.51% | 69,794 | - |
| 502 | ANEB | Anebulo Pharmaceuticals, Inc. | 14.68M | -16.49% | 684,944 | - |
| 503 | COCP | Cocrystal Pharma, Inc. | 14.47M | -0.94% | 49,734 | - |
| 504 | ITRM | Iterum Therapeutics plc | 13.97M | 12.08% | 809,480 | 390.00K |
| 505 | CLRB | Cellectar Biosciences, Inc. | 13.76M | -7.55% | 57,277 | - |
| 506 | BCDA | BioCardia, Inc. | 13.69M | 4.03% | 88,696 | 3.00K |
| 507 | QNTM | Quantum BioPharma Ltd. | 13.64M | -0.84% | 31,749 | - |
| 508 | NCEL | NewcelX Ltd. | 13.22M | 1.05% | 3,181 | - |
| 509 | TRAW | Traws Pharma, Inc. | 13.18M | 1.85% | 35,146 | 2.85M |
| 510 | GTBP | GT Biopharma, Inc. | 12.74M | 1.92% | 769,858 | - |
| 511 | KAPA | Kairos Pharma, Ltd. | 12.61M | 9.63% | 862,574 | - |
| 512 | BLRX | BioLineRx Ltd. | 12.49M | -1.74% | 8,234 | 12.74M |
| 513 | GDTC | CytoMed Therapeutics Limited | 12.46M | - | 53,975 | 573.19K |
| 514 | PHIO | Phio Pharmaceuticals Corp. | 12.27M | 6.54% | 550,287 | - |
| 515 | CDIO | Cardio Diagnostics Holdings, Inc. | 11.96M | 25.48% | 19,012,019 | 15.78K |
| 516 | SNGX | Soligenix, Inc. | 11.90M | 2.61% | 104,481 | 2.34K |
| 517 | LGVN | Longeveron Inc. | 11.55M | -6.66% | 266,610 | 1.44M |
| 518 | CMMB | Chemomab Therapeutics Ltd. | 11.45M | 20.00% | 288,674 | - |
| 519 | IMNN | Imunon, Inc. | 11.05M | 2.85% | 11,289 | - |
| 520 | PULM | Pulmatrix, Inc. | 10.92M | 2.75% | 12,355 | 3.00K |
| 521 | KALA | KALA BIO, Inc. | 10.73M | - | 205,829 | - |
| 522 | AKTX | Akari Therapeutics, Plc | 10.69M | -8.87% | 531,310 | - |
| 523 | OSRH | OSR Holdings, Inc. | 10.58M | -1.90% | 260,101 | -90.52K |
| 524 | BIVI | BioVie Inc. | 10.41M | 8.66% | 135,313 | - |
| 525 | ICU | SeaStar Medical Holding Corporation | 9.95M | 0.73% | 81,255 | 881.00K |
| 526 | MLEC | Moolec Science SA | 9.66M | -13.19% | 173,790 | 7.83M |
| 527 | NCNA | NuCana plc | 8.99M | -0.91% | 8,622 | - |
| 528 | LNAI | Lunai Bioworks Inc. | 8.96M | -7.38% | 297,372 | - |
| 529 | LIMN | Liminatus Pharma, Inc. | 8.94M | 10.05% | 4,337,785 | - |
| 530 | RNAZ | TransCode Therapeutics, Inc. | 8.81M | -5.51% | 18,104 | - |
| 531 | BOLT | Bolt Biotherapeutics, Inc. | 8.73M | -2.38% | 33,108 | 5.20M |
| 532 | CLGN | CollPlant Biotechnologies Ltd. | 7.96M | -0.35% | 130,468 | 2.48M |
| 533 | ERNA | Ernexa Therapeutics Inc. | 7.95M | -4.33% | 897,261 | 1,000.00 |
| 534 | GRDX | GridAI Technologies Corp. | 7.73M | -4.96% | 226,761 | - |
| 535 | KPRX | Kiora Pharmaceuticals, Inc. | 7.67M | -0.48% | 6,126 | 20.00K |
| 536 | CALC | CalciMedica, Inc. | 7.53M | -6.47% | 246,459 | - |
| 537 | ALZN | Alzamend Neuro, Inc. | 7.50M | -3.37% | 51,485 | - |
| 538 | EVGN | Evogene Ltd. | 7.44M | 1.99% | 15,064 | 8.02M |
| 539 | MBRX | Moleculin Biotech, Inc. | 7.36M | -0.83% | 70,632 | - |
| 540 | MBIO | Mustang Bio, Inc. | 7.33M | -1.94% | 32,261 | - |
| 541 | APVO | Aptevo Therapeutics Inc. | 7.30M | -0.41% | 10,938 | - |
| 542 | ADXN | Addex Therapeutics Ltd | 7.28M | 4.15% | 7,374 | 198.82K |
| 543 | TOVX | Theriva Biologics, Inc. | 7.13M | 1.52% | 2,726,122 | - |
| 544 | TCRT | Alaunos Therapeutics, Inc. | 7.12M | 1.59% | 17,516 | 6.00K |
| 545 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.02M | -1.65% | 13,329 | - |
| 546 | QNCX | Quince Therapeutics, Inc. | 7.00M | -9.24% | 26,859,671 | - |
| 547 | PMCB | PharmaCyte Biotech, Inc. | 6.99M | -1.97% | 78,188 | - |
| 548 | ASBP | Aspire Biopharma Holdings, Inc. | 6.98M | -4.14% | 57,111 | 1.94K |
| 549 | PHGE | BiomX Inc. | 6.96M | -4.38% | 31,966 | - |
| 550 | XTLB | XTL Biopharmaceuticals Ltd. | 6.64M | 0.18% | 10,982 | 968.00K |
| 551 | IMRN | Immuron Limited | 6.49M | -8.30% | 12,667 | 4.99M |
| 552 | APRE | Aprea Therapeutics, Inc. | 6.41M | 4.16% | 110,380 | 488.24K |
| 553 | APM | Aptorum Group Limited | 6.35M | -0.27% | 12,720 | - |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 6.33M | -1.63% | 15,862 | 6.00K |
| 555 | REVB | Revelation Biosciences, Inc. | 6.27M | -0.75% | 65,648 | - |
| 556 | CANF | Can-Fite BioPharma Ltd. | 6.00M | -3.65% | 33,498 | 560.00K |
| 557 | PPBT | Purple Biotech Ltd | 5.94M | -11.16% | 370,670 | - |
| 558 | CLDI | Calidi Biotherapeutics, Inc. | 5.82M | -6.07% | 24,786 | - |
| 559 | XBIO | Xenetic Biosciences, Inc. | 5.80M | 4.55% | 41,800 | 2.86M |
| 560 | VIVS | VivoSim Labs, Inc. | 5.66M | -2.69% | 108,229 | 142.00K |
| 561 | SLXN | Silexion Therapeutics Corp | 5.39M | -0.86% | 2,703 | - |
| 562 | CYCN | Cyclerion Therapeutics, Inc. | 5.14M | 3.05% | 71,961 | 2.86M |
| 563 | PCSA | Processa Pharmaceuticals, Inc. | 4.92M | -2.69% | 8,075 | - |
| 564 | SILO | Silo Pharma, Inc. | 4.88M | -3.50% | 300,677 | 72.10K |
| 565 | MTVA | MetaVia Inc. | 4.84M | -5.03% | 93,268 | - |
| 566 | BGMS | Bio Green Med Solution, Inc. | 4.80M | -2.97% | 3,697 | 81.00K |
| 567 | BRTX | BioRestorative Therapies, Inc. | 4.75M | -1.30% | 3,960,491 | 383.40K |
| 568 | GNPX | Genprex, Inc. | 4.64M | -6.10% | 457,487 | - |
| 569 | INDP | Indaptus Therapeutics, Inc. | 4.63M | - | 9,987 | - |
| 570 | DCOY | Decoy Therapeutics Inc. | 4.35M | -0.29% | 73,742 | - |
| 571 | GOVX | GeoVax Labs, Inc. | 4.20M | - | 20,322 | 3.35M |
| 572 | JAGX | Jaguar Health, Inc. | 4.03M | 4.01% | 925,805 | 11.79M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.02M | -5.92% | 16,760 | - |
| 574 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.00M | 5.07% | 31,968 | 1.36M |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 3.89M | 1.08% | 15,156 | - |
| 576 | ELAB | PMGC Holdings Inc. | 3.87M | -5.56% | 215,910 | 285.95K |
| 577 | ACXP | Acurx Pharmaceuticals, Inc. | 3.82M | -8.54% | 77,811 | - |
| 578 | GRI | GRI Bio, Inc. | 3.68M | -1.16% | 57,168 | - |
| 579 | OGEN | Oragenics, Inc. | 3.58M | -4.52% | 185,957 | - |
| 580 | ENVB | Enveric Biosciences, Inc. | 3.27M | 1.29% | 68,626 | - |
| 581 | HCWB | HCW Biologics Inc. | 3.11M | -1.64% | 28,999 | 422.03K |
| 582 | SCNI | Scinai Immunotherapeutics Ltd. | 3.08M | 3.45% | 15,304 | 1.15M |
| 583 | PPCB | Propanc Biopharma, Inc. | 3.06M | -1.13% | 218,615 | - |
| 584 | PBM | Psyence Biomedical Ltd. | 2.91M | -3.05% | 39,633 | - |
| 585 | XRTX | XORTX Therapeutics Inc. | 2.91M | 1.49% | 77,643 | - |
| 586 | DRMA | Dermata Therapeutics, Inc. | 2.86M | -4.00% | 184,157 | - |
| 587 | SPRC | SciSparc Ltd. | 2.82M | -5.29% | 20,351 | 1.31M |
| 588 | ADIL | Adial Pharmaceuticals, Inc. | 2.81M | - | 67,741 | - |
| 589 | ARTL | Artelo Biosciences, Inc. | 2.53M | -4.03% | 25,889 | - |
| 590 | ENSC | Ensysce Biosciences, Inc. | 2.28M | 57.77% | 282,465,091 | 4.49M |
| 591 | BBLG | Bone Biologics Corporation | 2.07M | 0.17% | 10,172 | - |
| 592 | CMND | Clearmind Medicine Inc. | 2.03M | -1.74% | 34,801 | - |
| 593 | CDT | CDT Equity Inc. | 2.01M | 5.40% | 151,599 | - |
| 594 | CNSP | CNS Pharmaceuticals, Inc. | 1.93M | 1.30% | 12,291 | - |
| 595 | AZTR | Azitra, Inc. | 1.88M | -3.85% | 986,541 | 7.50K |
| 596 | LYRA | Lyra Therapeutics, Inc. | 1.79M | -9.82% | 83,405 | 600.00K |
| 597 | VRAX | Virax Biolabs Group Limited | 1.69M | 3.03% | 78,306 | 2.99K |
| 598 | ONCO | Onconetix, Inc. | 1.04M | 1.36% | 37,167 | 1.22M |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 905.89K | -4.42% | 77,408 | 104.90K |
| 600 | ADTX | Aditxt, Inc. | 812.00K | -4.63% | 129,714 | 5.95K |